Is Endometriosis Hereditary? Genetics and Family Risk

• Endometriosis is polygenic and multifactorial — many genes and environmental factors combine, so it does not follow a simple parent-to-child inheritance pattern.
• Having a mother, sister or daughter with endometriosis raises your lifetime risk roughly 6–7 fold; heritability is estimated at about 50%, similar to type 2 diabetes or asthma.
• Family history is not destiny: about half of women with an affected mother never develop endometriosis.
• There is no clinically useful genetic test for endometriosis — direct-to-consumer "risk" tests are not endorsed by any gynaecology society.
• The single most useful action is recognising symptoms early. Severe period pain that disrupts school, work or life is not normal and deserves evaluation — especially with a family history.

Hereditary conditions sit on a spectrum. At one end are monogenic disorders, caused by a mutation in a single gene with a predictable inheritance pattern. At the other end are polygenic, multifactorial conditions, where many genes each add a small effect and interact with environment, hormones and lifestyle. Endometriosis sits firmly at the polygenic end.

Twin studies tell the clearest story. Identical (monozygotic) twins, who share all their genes, are far more likely to both have endometriosis than non-identical (dizygotic) twins, who share about half — strong evidence that genes matter. Family studies add to this: first-degree relatives (mother, sister, daughter) of a woman with endometriosis have roughly 6–7 times the lifetime risk of the general population, and second-degree relatives (grandmother, aunt, half-sister) around 2–3 times.

The estimated heritability is about 50%, meaning roughly half of the variation in who develops endometriosis traces to inherited factors. That is similar to other complex conditions like type 2 diabetes, asthma and inflammatory bowel disease. The other half reflects hormonal exposure, immune function, the pelvic and gut microbiome, and possibly epigenetic changes that switch gene activity up or down without altering the DNA itself. This is exactly why endometriosis clusters in families but never follows tidy Mendelian rules — and why a daughter of an affected mother is more likely, but not destined, to develop it.

Genome-wide association studies (GWAS) scan the entire genome to find variants linked to a disease. Large international endometriosis GWAS — pooling data from cohorts across Europe, North America, Asia and Australia — have now identified more than 40 susceptibility loci, with the list still growing as sample sizes climb.

The most consistently replicated signals cluster around biologically sensible pathways: hormonal signalling (oestrogen and progesterone receptor pathways), cell adhesion and the extracellular matrix (how endometrial-like cells implant and grow on pelvic surfaces), inflammation and immune function (the chronic inflammatory pelvic environment), and tissue remodelling. Well-replicated variants lie near genes such as WNT4, GREB1, ESR1 (oestrogen receptor 1), CDKN2B-AS1 and FN1, though the precise function of most remains under study.

Two caveats matter for any individual. First, each variant adds only a small effect — even the strongest GWAS hits raise risk by just 10–30% per copy. Polygenic risk scores that combine many variants are being developed but are not yet accurate enough for individual prediction in routine care. Second, most of this data comes from European-ancestry populations. How well these variants apply to South Asian women is still being worked out, and Indian centres including AIIMS and CMC Vellore are actively contributing to that research. Notably, many of these hormonal and inflammatory pathways overlap with other conditions — how endometriosis and PCOS differ and overlap is a common source of confusion.

• Tell your gynaecologist about any female relative with endometriosis, severe period pain, ovarian cysts or unexplained infertility.
• Mention ages at diagnosis and how severe the disease was, if you know.
• A positive family history plus suggestive symptoms should prompt earlier imaging — not a wait-and-see approach.

Genes set the stage, but several other factors decide how it plays out. Hormonal exposure is central. Early menarche (first period before age 12), short cycles (under 27 days), heavy bleeding, low BMI and never having been pregnant all increase the cyclical hormonal stimulation that drives endometriosis. A genetically susceptible woman with these features carries more risk than an equally susceptible woman with later menarche, longer cycles and pregnancies.

Factors that reduce ovulatory exposure appear modestly protective — pregnancy, breastfeeding and combined hormonal contraception among them. Lifestyle factors such as smoking, alcohol, diet, body weight and activity each probably contribute a little. The pelvic and gut microbiome may influence the inflammatory environment, and some endocrine-disrupting chemicals have been implicated, though that evidence remains debated. Stress, sleep and mood affect how pain is experienced and quality of life, but are not thought to cause endometriosis.

The practical takeaway: even with a strong family history, some risk is modifiable through reproductive choices and general health — but no intervention reliably prevents endometriosis. The goal is informed awareness, not anxiety. If your periods are unusually short, long or heavy, it is worth understanding what is okay and what is not with period pain.

For almost everyone, the answer today is no. Routine genetic testing for endometriosis is not recommended by any major society — ACOG, ESHRE, NICE, RCOG, FOGSI or the Indian Society of Endometriosis. The reasons are straightforward:

• No single gene reliably predicts endometriosis.
• Polygenic risk scores are not yet accurate enough to guide decisions for an individual.
• Identified variants have small effects (10–30%) that would not change your management.
• Diagnosis still rests on symptoms, examination, imaging and sometimes laparoscopy — regardless of any genetic result.
• A "negative" genetic test does not rule endometriosis out.

• Know the symptoms. Progressive period pain, deep pain during sex, cyclical bowel or bladder symptoms, chronic pelvic pain and difficulty conceiving are the classic signs. Watch for them in yourself.
• Do not normalise severe period pain. Pain that interferes with school, work or daily life warrants evaluation — regardless of family beliefs that period pain is simply to be endured.
• Track your cycles and symptoms. A period and symptom tracker helps you and your doctor spot patterns and shortens the path to answers.
• Seek evaluation sooner rather than later. Your family history shifts the clinical picture, and most gynaecologists take symptoms more seriously when there is a known relative.
• Talk to your partner and doctor about reproductive timing if relevant. Endometriosis affects fertility in 30–50% of cases, and earlier planning may matter for some families.
• Have the family conversation. Many extended Indian families quietly carry several women with undiagnosed gynaecological pain. Sharing a diagnosis can prompt sisters, cousins and daughters to seek their own earlier evaluation.

Endometriosis often begins in the teenage years — a fact still under-appreciated by families and many clinicians in India. In women later diagnosed, symptoms started in adolescence in 30–60% of cases, even though diagnosis often came a decade or more later.

For a girl with a family history, this matters enormously. Severe period pain that does not respond to standard NSAIDs, repeated school absences for cramps, pain bad enough to need repeated medical attention, or pelvic pain outside the period should prompt a gynaecology review — not another round of "it's normal." Adolescent endometriosis often shows up as continuous chronic pelvic pain rather than purely cyclical pain, and imaging findings can be subtle.

ESHRE specifically addresses adolescents, recommending early recognition and hormonal suppression for pain control, with laparoscopy reserved for when it is genuinely needed for diagnosis or treatment. Empirical hormonal treatment — often the combined pill used continuously or in extended cycles — is frequently the right first step, both for relief and possibly to slow progression. If period pain in a teen is severe or escalating, it deserves attention, not endurance. Adolescent gynaecology services at AIIMS, PGIMER, JIPMER and CMC Vellore increasingly offer this care, though awareness is still uneven outside major cities.

A family history of endometriosis intersects with fertility planning in a few ways. Women with an affected mother or sister who are thinking about future pregnancy may benefit from earlier reproductive-health assessment. AMH testing and antral follicle count (AMH typically ₹1,500–3,500) give a baseline picture of ovarian reserve, and pelvic imaging documents any current disease.

For women with both a diagnosis and a family history, an open conversation about timing — with both partner and a reproductive-medicine specialist — is sensible. Endometriosis can progress, and large endometriomas or deep disease may eventually need surgery that itself can affect ovarian reserve. This is not about rushing into an unwanted pregnancy; it is about making decisions with information rather than discovering reduced fertility years later.

If pregnancy is not currently the goal, hormonal suppression with the combined pill, a progestin, or the hormonal IUS controls symptoms and protects quality of life without reducing future fertility (though it does not actively preserve it either). For women with significant ovarian disease or anticipated delayed childbearing, egg freezing is increasingly considered — Indian fertility centres typically quote ₹1.5–3 lakh per cycle including medications and storage.

• Educate yourself about typical symptoms and learn to recognise them in your own body.
• Track your cycles and symptoms — pain severity, day-to-day pelvic discomfort, deep pain during sex, bowel and bladder symptoms, and mood — in an app or diary.
• Book a gynaecology consultation (₹600–2,500 OPD) if symptoms fit, and mention your family history at the visit.
• Expect a careful history, pelvic examination, transvaginal ultrasound (₹800–2,500), and sometimes a pelvic MRI (₹6,000–18,000) if deep disease is suspected.
• Hormonal treatment may be offered for symptom control even before a definitive diagnosis.
• A diagnostic or operative laparoscopy is offered when imaging and clinical picture warrant it.
• Ask for referral to a subspecialist endometriosis centre for moderate-to-severe disease, infertility, or failed first-line treatment.
• Most standard health policies cover endometriosis workup and surgery; IVF coverage varies — check your policy.
• Connect with patient support through the Endometriosis Society India and reputable online communities to reduce isolation and improve health literacy.

• Period pain that regularly stops you doing normal activities, or that is getting worse over time.
• Period pain that does not respond to standard over-the-counter pain relief such as NSAIDs.
• Deep pain during or after sex.
• Cyclical pain when passing urine or stools, or blood in urine or stool around your period.
• Chronic pelvic pain that occurs outside your period.
• Difficulty conceiving after 12 months of trying (or 6 months if you are over 35).
• Severe period pain in a teenager that disrupts school or daily life — do not wait.

• ESHRE Guideline: Endometriosis (2022)
• ACOG: Endometriosis (FAQ and Practice Resources)
• NHS: Endometriosis — Causes
• NICE Guideline NG73: Endometriosis — diagnosis and management
• World Health Organization: Endometriosis fact sheet